EUVIMEDEUVIMED entdecken
Crossref

Osteoclast Differentiation Factor in Human Osteosarcoma Cell Line

K Kinpara, M Mogi, M Kuzushima, A Togari

Journal of Immunoassay · 2000

DOI: 10.1080/01971520009349540 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Immunoassay, 2000. Verfasst von K Kinpara und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Dentistry, Aichi-Gakuin University, Nagoya, Japan. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnimalsCarrier ProteinsCell DifferentiationCross ReactionsEnzyme-Linked Immunosorbent AssayGlycoproteinsHumansMembrane GlycoproteinsMiceOsteoblastsOsteoclastsOsteoprotegerinOsteosarcomaProtein BindingRANK LigandReceptor Activator of Nuclear Factor-kappa BReceptors, Cytoplasmic and NuclearReceptors, Tumor Necrosis FactorTumor Cells, Cultured

Substanzen

Carrier ProteinsGlycoproteinsMembrane GlycoproteinsOsteoprotegerinRANK LigandReceptor Activator of Nuclear Factor-kappa BReceptors, Cytoplasmic and NuclearReceptors, Tumor Necrosis FactorTNFRSF11A protein, humanTNFRSF11B protein, human

Autor:innen und Institutionen

  • Department of Pharmacology, School of Dentistry, Aichi-Gakuin University, Nagoya, Japan.

Zitieren

APA

Kinpara, K., Mogi, M., Kuzushima, M., & Togari, A. (2000). Osteoclast Differentiation Factor in Human Osteosarcoma Cell Line. Journal of Immunoassay. https://doi.org/10.1080/01971520009349540

Vancouver

Kinpara K, Mogi M, Kuzushima M, Togari A. Osteoclast Differentiation Factor in Human Osteosarcoma Cell Line. Journal of Immunoassay. 2000. doi:10.1080/01971520009349540

BibTeX
@article{Kinpara2000,
  author = {Kinpara, K and Mogi, M and Kuzushima, M and Togari, A},
  title = {Osteoclast Differentiation Factor in Human Osteosarcoma Cell Line},
  journal = {Journal of Immunoassay},
  year = {2000},
  doi = {10.1080/01971520009349540}
}
Kostenlos starten →